Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GILEAD SCIENCES Latest News

1 HOUR AGO - TheStreet

A Must Read - Share

Roche, InterMune a Strategic Play in Midst of Inversions

NEW YORK (The Deal) -- In 2003, Foster City, Calif.'s Gilead Sciences apurchased Durham, N.C.'s Triangle Pharmaceuticals for $464 million. Daniel Welch, CEO of Triangle at the time, was a key player in the transaction. Soon after his gig was up at Triangle, Welch joined InterMune aas president and CEO. So it's no surprise that Welch's InterMune is now merging ...

Tags: Roche, InterMune a Strategic Play in Midst of Inversions,  Gilead Sciences Latest News

15 HOURS AGO - TheStreet

A Must Read - Share

Jim Cramer's 'Mad Money' Recap: A Monster of An August

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- With the market near completing its best August in 14 years, Jim Cramer told his Mad Money viewers Tuesday there's not much to fear at these levels but there is still a lot to embrace. Just how did the market achieve such ...

Tags: Jim Cramer's 'Mad Money' Recap: A Monster of An August,  Gilead Sciences Latest News

AUG 26, 2014 - Business Insider

A Must Read - Share

Futures Flat, Few Incentives To Buy; S&P 500 Off Record

By Ryan VlastelicaNEW YORK (Reuters) - U.S. stock index futures were little changed on Tuesday, with investors finding few reasons to buy after a rally in the previous session that took the S&P 500 above 2,000 for the first time.The S&P failed to hold that level on Monday, though the benchmark index ended at a new closing high. Equities have ...

Tags: Futures Flat, Few Incentives To Buy; S&P 500 Off Record,  Gilead Sciences Latest News

AUG 25, 2014 - TheStreet

A Must Read - Share

One Factor Driving Gilead Sciences (GILD) Stock Up to a One-Year High Today

NEW YORK (TheStreet) --aGilead Sciencesa hit a new 52-week high of $107.40 as of 11:07 a.m. on Monday. The biotech sector rose Monday after Swiss-based companyaRocheaagreed to buyaInterMuneaITMN for $8.3 billion in an all-cash deal. The news sent several biotech stocks, includingaGilead, RegeneronaREGN andaCelgeneaCELG, higher in morning trading. Must Read: Warren Buffett's 25 Favorite Stocks STOCKS TO BUY: TheStreet Quant ...

Tags: One Factor Driving Gilead Sciences (GILD) Stock Up to a One-Year High Today,  Gilead Sciences Latest News

AUG 25, 2014 - Yahoo! News

A Must Read - Share

S&P 500 tops 2,000 for first time in broad advance

By Ryan Vlastelica NEW YORK (Reuters) - The S&P 500 stock index rose to an intraday record on Monday, topping 2,000 for the first time in a broad rally led by financial and biotechnology stocks. Biotechs rallied after Roche Holding AG agreed to buy InterMune Inc for $8.3 billion in cash, the latest vote of confidence in a sector that ...

Tags: S&P 500 tops 2,000 for first time in broad advance,  Gilead Sciences Latest News